Arman Rahmim Selected Research

4- cyano- 1- (2,4- dichlorophenyl)- 5- (4- methoxyphenyl)- N- (piperidin- 1- yl)- 1H- pyrazole- 3- carboxamide

10/2010

Quantification of cerebral cannabinoid receptors subtype 1 (CB1) in healthy subjects and schizophrenia by the novel PET radioligand [11C]OMAR.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Arman Rahmim Research Topics

Disease

13	Neoplasms (Cancer) 06/2022 - 10/2013
4	Parkinson Disease (Parkinson's Disease) 01/2021 - 01/2017
3	Dementia (Dementias) 10/2022 - 08/2016
3	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2021
3	Sarcoma (Soft Tissue Sarcoma) 01/2022 - 01/2020
3	Nasopharyngeal Carcinoma 01/2020 - 12/2016
3	Atherosclerosis 04/2017 - 09/2010
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 06/2022 - 01/2021
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2020
2	Squamous Cell Carcinoma of Head and Neck 05/2017 - 09/2016
2	Adenocarcinoma 03/2016 - 01/2016
1	Head and Neck Neoplasms (Head and Neck Cancer) 03/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	COVID-19 01/2021
1	Seizures (Absence Seizure) 01/2020
1	Inflammation (Inflammations) 01/2020
1	Hypertension (High Blood Pressure) 04/2017
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/2016
1	Parkinsonian Disorders (Parkinsonism) 01/2016
1	Schizophrenia (Dementia Praecox) 10/2010
1	Substance-Related Disorders (Drug Abuse) 10/2006
1	Obesity 10/2006

Drug/Important Bio-Agent (IBA)

3	Amyloid (Amyloid Fibrils)IBA 10/2022 - 08/2016
3	florbetapirIBA 10/2022 - 08/2016
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 03/2022 - 05/2017
3	Pharmaceutical PreparationsIBA 01/2022 - 02/2017
3	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2021 - 01/2016
3	Glucose (Dextrose)FDA LinkGeneric 10/2019 - 12/2016
2	AntigensIBA 01/2022 - 01/2021
2	RadiopharmaceuticalsIBA 01/2022 - 01/2021
2	ErbB Receptors (EGF Receptor)IBA 01/2022 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 12/2019
2	Apolipoproteins E (ApoE)IBA 04/2017 - 08/2016
2	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 10/2010 - 10/2006
1	Peptides (Polypeptides)IBA 06/2022
1	Radioisotopes (Radionuclides)IBA 06/2022
1	Peptide Receptors (Peptide Receptor)IBA 06/2022
1	SodiumIBA 01/2022
1	Epoxy Resins FDA Link 01/2022
1	Angiogenesis InhibitorsIBA 01/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022
1	N-Methylaspartate (NMDA)IBA 01/2020
1	CholesterolIBA 04/2017
1	SDMIBA 02/2017
1	Choline (Choline Chloride)IBA 12/2016
1	A 113IBA 01/2016
1	Complement System Proteins (Complement)IBA 10/2013
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 10/2010
1	4- cyano- 1- (2,4- dichlorophenyl)- 5- (4- methoxyphenyl)- N- (piperidin- 1- yl)- 1H- pyrazole- 3- carboxamideIBA 10/2010
1	CannabinoidsIBA 10/2010
1	CalciumIBA 09/2010

Therapy/Procedure

8	Therapeutics 06/2022 - 03/2016
3	Radiotherapy 12/2020 - 01/2016
2	Drug Therapy (Chemotherapy) 01/2022 - 01/2021
1	Castration 03/2021
1	Animal Assisted Therapy 01/2020
1	Chemoradiotherapy 09/2016